Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors
Saved in:
Main Authors: | Chuansumrit,A., Sirachainan,N., Panuwannakorn,M., Wongwerawattanakoon,P., Kadegasem,P., Choeyprasert,W., Sasanakul,W. |
---|---|
Format: | Article |
Published: |
Wiley-Blackwell
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84876816089&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38264 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors
by: A. Chuansumrit, et al.
Published: (2018) -
Rituximab as an adjuvant therapy to immune tolerance in a haemophilia A boy with high inhibitor titre
by: Ampaiwan Chuansumrit, et al.
Published: (2018) -
Efficacy of different doses of recombinant activated factor VII in the treatment of haemophilia children with inhibitor
by: Ampaiwan Chuansumrit, et al.
Published: (2018) -
Prenatal diagnosis for haemophilia: the Thai experience
by: A. Chuansumrit, et al.
Published: (2018) -
Simple and accurate bedside diagnostic kit for determining haemophilia A and B: A revised version
by: W. Sasanakul, et al.
Published: (2018)